Patient characteristics of 106 matched imatinib-treated patients and 53 patients who underwent transplantation in first CP (matched pair analysis)
| . | Transplantation . | Imatinib . |
|---|---|---|
| No. | 53 | 106 |
| Sex, % male | 56.6 | 56.6 |
| Median age, y | 37 | 36.5 |
| EURO risk score, % | ||
| Low | 41.5 | 41.5 |
| Intermediate | 35.8 | 35.8 |
| High | 22.6 | 22.6 |
| . | Transplantation . | Imatinib . |
|---|---|---|
| No. | 53 | 106 |
| Sex, % male | 56.6 | 56.6 |
| Median age, y | 37 | 36.5 |
| EURO risk score, % | ||
| Low | 41.5 | 41.5 |
| Intermediate | 35.8 | 35.8 |
| High | 22.6 | 22.6 |
Matching criteria were age, sex, risk profile, disease phase, and interval to transplantation.
CP indicates first chronic phase.